BBIOVSCDT• 28 Days (Normalized)
BBIO vs CDT (BridgeBio Pharma Inc. vs CDT Equity Inc.)
Showing Closing Date Range from Sep 11 to Oct 9, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBIO Performance $65.35
-9.79%
BridgeBio Pharma Inc.
Normalized Baseline0.00%
CDT Performance $0.72
-88.51%
CDT Equity Inc.
Normalized Baseline0.00%
Alpha Spread Margin BBIO LEADS
+78.72 pts
BBIO outperforming by 78.72 percentage points
BBIOCDT
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBIO CDT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | BBIO Price | BBIO Gain (%) | CDT Price | CDT Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 09, 2026 | $65.35 | -9.79% | $0.72 | -88.51% | +78.72% |
| Oct 08, 2026 | $65.04 | -10.22% | $0.80 | -87.20% | +76.98% |
| Oct 07, 2026 | $66.50 | -8.20% | $0.84 | -86.62% | +78.42% |
| Oct 06, 2026 | $66.96 | -7.56% | $0.93 | -85.12% | +77.56% |
| Oct 05, 2026 | $66.14 | -8.70% | $0.92 | -85.32% | +76.62% |
| Oct 02, 2026 | $67.25 | -7.16% | $0.99 | -84.16% | +77.00% |
| Oct 01, 2026 | $- | $1.25 | -80.00% | - | |
| Sep 30, 2026 | $- | $1.36 | -78.24% | - | |
| Sep 29, 2026 | $- | $1.45 | -76.80% | - | |
| Sep 28, 2026 | $- | $1.90 | -69.60% | - | |
| Sep 25, 2026 | $65.25 | -9.92% | $2.00 | -68.00% | +58.08% |
| Sep 24, 2026 | $66.28 | -8.50% | $3.03 | -51.60% | +43.10% |
| Sep 23, 2026 | $65.71 | -9.29% | $3.38 | -46.00% | +36.71% |
| Sep 22, 2026 | $69.23 | -4.43% | $3.55 | -43.20% | +38.77% |
| Sep 21, 2026 | $66.58 | -8.09% | $3.85 | -38.40% | +30.31% |
Page 1 of 2